16-2085072-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000548.5(TSC2):​c.4569+46C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0136 in 1,610,540 control chromosomes in the GnomAD database, including 183 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 14 hom., cov: 34)
Exomes 𝑓: 0.014 ( 169 hom. )

Consequence

TSC2
NM_000548.5 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4O:1

Conservation

PhyloP100: 0.450

Publications

4 publications found
Variant links:
Genes affected
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC2 Gene-Disease associations (from GenCC):
  • tuberous sclerosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • tuberous sclerosis 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics
  • lymphangioleiomyomatosis
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • tuberous sclerosis complex
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 16-2085072-C-T is Benign according to our data. Variant chr16-2085072-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 49857.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0105 (1595/152328) while in subpopulation NFE AF = 0.0187 (1270/68024). AF 95% confidence interval is 0.0178. There are 14 homozygotes in GnomAd4. There are 726 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High AC in GnomAd4 at 1595 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSC2NM_000548.5 linkc.4569+46C>T intron_variant Intron 35 of 41 ENST00000219476.9 NP_000539.2 P49815-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSC2ENST00000219476.9 linkc.4569+46C>T intron_variant Intron 35 of 41 5 NM_000548.5 ENSP00000219476.3 P49815-1

Frequencies

GnomAD3 genomes
AF:
0.0105
AC:
1595
AN:
152210
Hom.:
14
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00234
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00602
Gnomad ASJ
AF:
0.0107
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00290
Gnomad FIN
AF:
0.00527
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0187
Gnomad OTH
AF:
0.0115
GnomAD2 exomes
AF:
0.0103
AC:
2564
AN:
249256
AF XY:
0.0102
show subpopulations
Gnomad AFR exome
AF:
0.00255
Gnomad AMR exome
AF:
0.00501
Gnomad ASJ exome
AF:
0.0101
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.00714
Gnomad NFE exome
AF:
0.0171
Gnomad OTH exome
AF:
0.0120
GnomAD4 exome
AF:
0.0139
AC:
20268
AN:
1458212
Hom.:
169
Cov.:
32
AF XY:
0.0137
AC XY:
9910
AN XY:
725618
show subpopulations
African (AFR)
AF:
0.00260
AC:
87
AN:
33404
American (AMR)
AF:
0.00503
AC:
225
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.0109
AC:
284
AN:
26122
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39680
South Asian (SAS)
AF:
0.00355
AC:
306
AN:
86172
European-Finnish (FIN)
AF:
0.00760
AC:
397
AN:
52226
Middle Eastern (MID)
AF:
0.00451
AC:
26
AN:
5762
European-Non Finnish (NFE)
AF:
0.0164
AC:
18213
AN:
1109872
Other (OTH)
AF:
0.0120
AC:
726
AN:
60278
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1223
2446
3668
4891
6114
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
642
1284
1926
2568
3210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0105
AC:
1595
AN:
152328
Hom.:
14
Cov.:
34
AF XY:
0.00975
AC XY:
726
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.00233
AC:
97
AN:
41570
American (AMR)
AF:
0.00601
AC:
92
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0107
AC:
37
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5186
South Asian (SAS)
AF:
0.00290
AC:
14
AN:
4828
European-Finnish (FIN)
AF:
0.00527
AC:
56
AN:
10626
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0187
AC:
1270
AN:
68024
Other (OTH)
AF:
0.0114
AC:
24
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
80
159
239
318
398
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0151
Hom.:
43
Bravo
AF:
0.00958
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 15, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Tuberous sclerosis 2 Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Tuberous sclerosis syndrome Other:1
-
Tuberous sclerosis database (TSC2)
Significance:not provided
Review Status:no classification provided
Collection Method:curation

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.76
DANN
Benign
0.36
PhyloP100
0.45
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45482793; hg19: chr16-2135073; COSMIC: COSV51923988; COSMIC: COSV51923988; API